Chris Broomell

Chris Broomell

Company: Omega Therapeutics, Inc.

Job title: Head of Analytical Development


Roundtable discussion – Tackling Impurity Thresholds to Review the Required Target with an Appreciation of Degradation Impact 12:00 pm

Reviewing what ‘good’ looks like when striving for purity  Correlating impurity metrics with risk of degradation  Discussing realistic purity metrics to maximise control as well time efficiency Read more

day: Conference Day One

A Hanson Wade Group Company

© Copyright 2024 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Eastcastle House, 27/28 Eastcastle Street, London, W1W 8DH.